To view this page ensure that Adobe Flash Player version 11.1.0 or greater is installed.
Foreword Richard Alan Rison
Clinical Assistant Professor of Neurology, Keck School of Medicine, University of Southern California, California, US
Richard Alan Rison is a deputy editor of the Journal of Medical Case Reports; an associate neurology editor of BMC Neurology, Grand Rounds,
and WebmedCentral; and lead editor for case reports of BMC Research Notes. Dr Rison practices general neurology at Neurology Consultants
Medical Group, serves as medical director of the PIH Health Hospital-Whittier Stroke Program and the PIH Health Hospital-Whittier Non-
Invasive Vascular Laboratory, is a clinical assistant professor of neurology at the University of Southern California Keck School of Medicine and
Los Angeles County Medical Center, and is a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine. Dr Rison
is board-certified by the American Board of Psychiatry and Neurology in neurology and vascular neurology, and neurocritical care and
neuroimaging by the United Council of Neurologic Subspecialties. He is also board-certified by the American Board of Electrodiagnostic
Medicine in electrodiagnostic medicine. Dr Rison is a former president of the Los Angeles Neurological Society and is a fellow of the American
Academy of Neurology and the American Neurological Association.
W elcome to the latest edition of US Neurology, which features a wide range of articles that reflect the rapid
pace of progress in neurology. We begin with two review articles on the subject of chronic inflammatory
demyelinating polyradiculoneuropathy (CIDP) a challenging condition as it can mimic other neuropathies
and can lead to chronic disability if not diagnosed and treated at an early stage. In the first, Beydoun et al. provide
an introduction to diagnosis and treatment. In the second, Allen et al. discuss the various outcome measures used
during the assessment of patients with CIDP.
Loss of respiratory function remains a significant cause of early morbidity and mortality in Duchenne muscular dystrophy
(DMD). Henricson et al. discuss recent advances in understanding of the natural history of respiratory decline in DMD, as well
as clinical trial data demonstrating the utility of idebenone in reducing this decline.
Also in this issue, Yeshokumar and Banwell discuss the challenges of management of multiple sclerosis (MS) in children, when
many disease-modifying therapies are only recently being tested in pediatric populations. A multidisciplinary approach is
required to optimize strategies for the individual child or teenager. In addition, Gross et al. present a review of recent advances
in the pathophysiology, natural history and treatment approaches for cerebral dural arteriovenous fistula, a heterogeneous
collection of vascular shunts that have varied clinical presentations and can be difficult to treat.
The clostridial neurotoxins, including tetanus toxin and botulinum neurotoxins A and D are among the deadliest agents
known. In an editorial, Silberstein describes the spread of these toxins via intraneuron transfer. Finally, Sperling describes the
highlights of the recent American Epilepsy Society annual meeting, including a new classification system that should simplify
diagnosis, ensuring earlier identification of epilepsy and more prompt treatment
US Neurology would like to take this opportunity to thank all participants on this edition, from organizations to individuals.
A special thanks goes to our Editorial Board for their continuing support and guidance. In particular, we are grateful to the
expert authors, who gave their valuable time and effort to produce these insightful articles. The variety of topics covered
in this issue should ensure there is something of interest for every reader and we hope you find this edition useful and
TOU CH MED ICA L MEDIA